HOME HELP FEEDBACK TABLE OF CONTENTS ARCHIVE SUBSCRIPTIONS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Piñol, M. Articles by Federici, A. B. Search for Related Content PubMed PubMed Citation Articles by Piñol, M. Articles by Federici, A. B.

Evaluation of a new turbidimetric assay for von Willebrand factor activity useful in the general screening of von Willebrand disease

^* Biokit S.A., Lliçà d’Amunt, Barcelona, Spain;
^{^} Department of Hematology and Hemophilia and Thrombosis Center San Bortolo Hospital, Vicenza, Italy;
^# Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Department of Internal Medicine and Medical Specialties, IRCCS Foundation Maggiore Policlinico Hospital, Mangiagalli, Regina Elena and University of Milan, Italy

Correspondence: Miquel Sales, Biokit SA, Lliçà d’Amunt, Barcelona, Spain. E-mail: msales{at}biokit.com

We evaluated a new assay (HemosIL^TMVWF Activity on ACL-Futura) in the screening of VWD. Samples from healthy donors and previously diagnosed VWD patients were blindly analyzed by this new activity assay and standard VWF:RCo. Results agreed and both assays showed a similar sensitivity for the screening of VWD.

Key words: von Willebrand factor, von Willebrand disease, von Willebrand factor activity, automated assay, latex immunoassay.